Scilex Holding Co (SCLX) stock
SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.25−0.18 (-12.59%)
Close on Nov 16, 2026Market cap $10.62MP/E –Yield –
Scilex price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Scilex's price to sales ratio was 0.4× on Nov 10, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 0.4× to 32.1×, with a median of 2.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 0.4× | −1.4 |
| 2025 | Dec 31, 2025 | 1.8× | +0.8 |
| 2024 | Dec 31, 2024 | 1.0× | −3.2 |
| 2023 | Dec 29, 2023 | 4.2× | −2.8 |
| 2022 | Jan 31, 2022 | 7.0× | +0.0 |
| 2021 | Dec 31, 2021 | 7.0× | – |
See a number that looks wrong?